Cargando…

Complete remission of nephrotic syndrome in a young woman with anti-LRP2 nephropathy after immunosuppressive therapy

BACKGROUND: Anti-low density lipoprotein receptor-related protein 2 (LRP2) nephropathy/anti-brush border antibody (ABBA) disease is a disorder characterized by acute tubulointerstitial injury associated with circulating antibodies to kidney proximal tubular brush border protein LRP2/megalin. Patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Xiaoye, Tu, Lingxue, Liu, Shaojun, You, Huaizhou, Xue, Jun, Hao, Chuanming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446201/
https://www.ncbi.nlm.nih.gov/pubmed/32831033
http://dx.doi.org/10.1186/s12882-020-02027-w
_version_ 1783574121155657728
author Zhu, Xiaoye
Tu, Lingxue
Liu, Shaojun
You, Huaizhou
Xue, Jun
Hao, Chuanming
author_facet Zhu, Xiaoye
Tu, Lingxue
Liu, Shaojun
You, Huaizhou
Xue, Jun
Hao, Chuanming
author_sort Zhu, Xiaoye
collection PubMed
description BACKGROUND: Anti-low density lipoprotein receptor-related protein 2 (LRP2) nephropathy/anti-brush border antibody (ABBA) disease is a disorder characterized by acute tubulointerstitial injury associated with circulating antibodies to kidney proximal tubular brush border protein LRP2/megalin. Patients are typically elderly and present with acute kidney injury and subnephrotic proteinuria. They progress to end-stage renal disease with poor response to immunosuppressive therapies. CASE PRESENTATION: We report a case of a 29-year-old Chinese woman, who presented with nephrotic syndrome with normal kidney function. Kidney biopsy showed no obvious tubular injury or interstitial inflammation. Positive immunoglobulin G (IgG) staining was revealed along the brush border of proximal tubular cells. Anti-LRP2 antibody was identified in serum, consistent with a diagnosis of anti-LRP2 nephropathy. The patient achieved complete remission after receiving prednisone and cyclophosphamide. CONCLUSIONS: Anti-LRP2 nephropathy can also present as nephrotic syndrome in young patients and complete remission from nephrotic syndrome may be achieved after immunosuppressive therapy.
format Online
Article
Text
id pubmed-7446201
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-74462012020-08-26 Complete remission of nephrotic syndrome in a young woman with anti-LRP2 nephropathy after immunosuppressive therapy Zhu, Xiaoye Tu, Lingxue Liu, Shaojun You, Huaizhou Xue, Jun Hao, Chuanming BMC Nephrol Case Report BACKGROUND: Anti-low density lipoprotein receptor-related protein 2 (LRP2) nephropathy/anti-brush border antibody (ABBA) disease is a disorder characterized by acute tubulointerstitial injury associated with circulating antibodies to kidney proximal tubular brush border protein LRP2/megalin. Patients are typically elderly and present with acute kidney injury and subnephrotic proteinuria. They progress to end-stage renal disease with poor response to immunosuppressive therapies. CASE PRESENTATION: We report a case of a 29-year-old Chinese woman, who presented with nephrotic syndrome with normal kidney function. Kidney biopsy showed no obvious tubular injury or interstitial inflammation. Positive immunoglobulin G (IgG) staining was revealed along the brush border of proximal tubular cells. Anti-LRP2 antibody was identified in serum, consistent with a diagnosis of anti-LRP2 nephropathy. The patient achieved complete remission after receiving prednisone and cyclophosphamide. CONCLUSIONS: Anti-LRP2 nephropathy can also present as nephrotic syndrome in young patients and complete remission from nephrotic syndrome may be achieved after immunosuppressive therapy. BioMed Central 2020-08-24 /pmc/articles/PMC7446201/ /pubmed/32831033 http://dx.doi.org/10.1186/s12882-020-02027-w Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Case Report
Zhu, Xiaoye
Tu, Lingxue
Liu, Shaojun
You, Huaizhou
Xue, Jun
Hao, Chuanming
Complete remission of nephrotic syndrome in a young woman with anti-LRP2 nephropathy after immunosuppressive therapy
title Complete remission of nephrotic syndrome in a young woman with anti-LRP2 nephropathy after immunosuppressive therapy
title_full Complete remission of nephrotic syndrome in a young woman with anti-LRP2 nephropathy after immunosuppressive therapy
title_fullStr Complete remission of nephrotic syndrome in a young woman with anti-LRP2 nephropathy after immunosuppressive therapy
title_full_unstemmed Complete remission of nephrotic syndrome in a young woman with anti-LRP2 nephropathy after immunosuppressive therapy
title_short Complete remission of nephrotic syndrome in a young woman with anti-LRP2 nephropathy after immunosuppressive therapy
title_sort complete remission of nephrotic syndrome in a young woman with anti-lrp2 nephropathy after immunosuppressive therapy
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446201/
https://www.ncbi.nlm.nih.gov/pubmed/32831033
http://dx.doi.org/10.1186/s12882-020-02027-w
work_keys_str_mv AT zhuxiaoye completeremissionofnephroticsyndromeinayoungwomanwithantilrp2nephropathyafterimmunosuppressivetherapy
AT tulingxue completeremissionofnephroticsyndromeinayoungwomanwithantilrp2nephropathyafterimmunosuppressivetherapy
AT liushaojun completeremissionofnephroticsyndromeinayoungwomanwithantilrp2nephropathyafterimmunosuppressivetherapy
AT youhuaizhou completeremissionofnephroticsyndromeinayoungwomanwithantilrp2nephropathyafterimmunosuppressivetherapy
AT xuejun completeremissionofnephroticsyndromeinayoungwomanwithantilrp2nephropathyafterimmunosuppressivetherapy
AT haochuanming completeremissionofnephroticsyndromeinayoungwomanwithantilrp2nephropathyafterimmunosuppressivetherapy